ACE and neoplasm: Furthermore, DCP-IL-12/FLT3L augmented both CD8+ and total CD3+ T cells, but eliminating CD8+ T cells did not decrease overall CD3+ T cell numbers, suggesting compensatory tumor infiltration by CD3+CD8− T cells.